T cell tolerance to germline-encoded antibody sequences in a lupus-prone mouse

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2184-2190

  Guo, Wenzhong ^a   Smith, Diana ^a   Guth, Amanda ^b   Aviszus, Katja ^a   Wysocki, Lawrence J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CHROMATIN; CONTROLLED STUDY; FEMALE; HYBRIDOMA; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 23444449751     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2184     Document Type: Article

References (57)

1. Pisetsky, D. S. 1986. Systemic lupus erythematosus. Med. Clin. N. Am. 70: 337-353.
2. Tan, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-151.
3. Datta, S. K. 1988. Murine lupus. Methods Enzymol. 162: 385-412.
4. Liang, Z., C. Xie, C. Chen, D. Kreska, K. Hsu, L. Li, X. J. Zhou, and C. Mohan. 2004. Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J. Exp. Med. 199: 381-398.
5. Sobel, E. S., V. N. Kakkanaiah, M. Kakkanaiah, R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1994. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 152: 6011-6016.
6. Bloom, D. D., E. W. St. Clair, D. S. Pisetsky, and S. H. Clarke. 1994. The anti-La response of a single MRL/Mp-lpr/lpr mouse: specificity for DNA and VH gene usage. Eur. J. Immunol. 24: 1332-1338.
7. Datta, S. K. 1998. Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells. Lupus 7: 591-596.
8. Finck, B. K., P. S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265: 1225-1227.
9. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179: 1137-1143.
10. Railed, S. L., A. H. Cutler, S. K. Datta, and D. W. Thomas. 1998. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160: 2158-2165.
11. 1 mouse. J. Immunol. 145: 2322-2332.
12. Portanova, J. P., G. Creadon, X. Zhang, D. S. Smith, B. L. Kotzin, L. J. Wysocki, and J. Ellenberger. 1995. An early post-mutational selection event directs expan-sion of autoreactive B cells in murine lupus. Mol. Immunol. 32: 117-135.
13. Shlomchik, M., M. Mascelli, H. Shan, M. Z. Radie, D. Pisetsky, A. Marshak-Rothstein, and M. Weigert. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171: 265-292.
14. Shlomchik, M. J., A. H. Aucoin, D. S. Pisetsky, and M. G. Weigert. 1987. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA 84: 9150-9154.
15. Shlomchik, M. J., A. Marshak-Rothstein, C. B. Wolfowicz, T. L. Rothstein, and M. G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805-811.
16. Winkler, T. H., H. Fehr, and J. R. Kalden. 1992. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur. J. Immunol. 22: 1719-1728.
17. 17: Wofsy, D., J. A. Ledbetter, P. L. Hendler, and W. E. Seaman. 1985. Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134: 852-857.
18. Bell, D. A., B. Morrison, and P. VandenBygaart. 1990. Immunogenic DNA-related factors: nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85: 1487-1496.
19. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381.
20. 20: Kaliyaperumal, A., C. Mohan, W. Wu, and S. K. Datta. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183: 2459-2469.
21. Datta, S. K., and A. Kaliyaperumal. 1997. Nucleosome-driven autoimmune response in lupus: pathogenic T helper cell epitopes and costimulatory signals. Ann. NY Acad. Sci. 815: 155-170.
22. Cobke, M. S., N. Mistry, C. Wood, K. E. Herbert, and J. Lunec. 1997. Immunogenicity of DNA damaged by reactive oxygen species: implications for anti-DNA antibodies in lupus. Free Radical Biol. Med. 22: 151-159.
23. Hottelet, M., W. J. van Venrooij, P. Anderson, and P. J. Utz. 1998. Proteins phosphprylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J. Exp. Med. 187: 547-560.
24. Rubin, B.; and G. Sønderstrup. 2004. Citrullination of self-proteins and autoimmunity. Scand. J. Immunol. 60: 112-120.
25. Jorgensen, T., B. Bogen, and K. Hannestad. 1983. T helper cells recognize an idiptope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315). J. Exp. Med. 158: 2183-2188.
26. Bogen, B., T. Jorgensen, and K. Hannestad. 1985. T helper cell recognition of idiptopes on λ2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region. Eur. J. Immunol. 15: 278-281.
27. Singh, R. R., V. Kumar, F. M. Ebling, S. Southwood, A. Sette, E. E. Sercarz, and B. H. Hahn. 1995. T cell determinants-from autoantibodies to DNA can upregulated autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181: 2017-2027.
28. Singh, R. R., F. M. Ebling, E. E. Sercarz, and B. H. Hahn 1995. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J. Clin. Invest. 96: 2990-2996.
29. Snyder, C. M., X. Zhang, and L. J. Wysocki. 2002. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells. J. Immunol. 168: 3865-3873.
30. Hahn, B. H., R. R. Singh, B. P. Tsao, and F. M. Ebling. 1997. Peptides from Vh regions of antibodies to DNA activate T cell help to upregulate autoantibody synthesis. Lupus 6: 330-332.
31. Hahn, B. H., R. R. Singh, and F. M. Ebling. 1998. Self Ig peptides that help anti-DNA antibody production: importance of charged residues. Lupus 7: 307-313.
32. Eyerman, M. C., X. Zhang, and L. J. Wysocki. 1996. T cell recognition and tolerance of antibody diversity. J. Immunol. 157: 1037-1046.
33. Eyerman, M. C., and L. Wysocki. 1994. T cell recognition of somatically-generated Ab diversity. J. Immunol. 152: 1569-1577.
34. Bartnes, K., and K. Hannestad. 1997. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules. Eur. J. Immunol. 27: 1124-1130.
35. Zhang, X., D. S. Smith, A. Guth, and L. J. Wysocki. 2001. A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J. Immunol. 166: 1562-1571.
36. 1 lupus-prone mice. Immunol. Lett. 72: 61-68.
37. Brosh, N., E. Eilat, H. Zinger, and E. Mozes. 2000. Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity- determining region-3 of a pathogenic anti-DNA monoclonal antibody. Immunology 99: 257-265.
38. 1 mouse model of systemic lupus erythematosus. Arthritis Rheum. 36: 355-364.
39. Holmoy, T., B. Vandvik, and F. Vandal. 2003. T cells from multiple sclerosis patients recognize irnmunoglobulin G from cerebrospinal fluid. Mult. Scler. 9: 228-234.
40. Williams, W. M., N. A. Staines, S. Muller, and D. A. Isenberg. 1995. Human T cell responses to autoantibody variable region peptides. Lupus 4: 464-471.
41. Singh, R. R., B. H. Hahn, B. P. Tsao, and F. M. Ebling. 1998. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J. Clin. Invest. 102: 1841-1849.
42. Singh, R, R., and B. H. Hahn. 1998. Reciprocal T-B determinant spreading de-velops spontaneously in murine lupus: implications for pathogenesis. Immunol. Rev. 164: 201-208.
43. Kalsi, J. K., and B. H. Hahn. 2002. The role of VH determinants in systemic lupus erythematosus. Lupus 11: 878-884.
44. Liu, A. H., P. K. Jena, and L. J. Wysocki. 1996. Tracing the development of single memory-lineage B cells in a highly denned immune response. J. Exp. Med. 183: 2053-2063.
45. Pascual, V., Y. J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180: 329-339.
46. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173: 1165-1175.
47. Jacob, J., and G. Kelsoe. 1992. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J. Exp. Med. 176: 679-687.
48. Jacob, J., J. Przylepa, C. Miller, and G. Kelsoe. 1993. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J. Exp. Med. 178: 1293-1307.
49. Berek, C., G. M. Griffiths, and C. Milstein. 1985. Molecular events maturation of the immune response to oxazolone. Nature 316: 412-418.
50. Vora, K. A., K. Tumas-Brundage, and T. Manser. 1999. Contrasting the in situ behavior of a memory B cell clone during primary and secondary immune responses. J. Immunol. 163: 4315-4327.
51. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143: 1822-1825.
52. Sompuram, S. R., and J. Sharon. 1993. Verification of a model F(ab) complex with phenylarsonate by olionucleotide-directed mutagenesis. J. Immunol. 150: 1822-1828.
53. + T cells reactive to an immunoglobulin variable region. J. Exp. Med. 200: 1-11.
54. Singh, R. R., F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn. 2002: Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 169: 587-594.
55. Lou, Q., R. J. Kelleher, Jr., A. Sette, J. Loyall, S. Southwood, R. B. Bankert, and S. H. Bernstein. 2004. Germ line tumor-associated immunoglobulin VH region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells. Blood 104: 752-759.
56. Bendandi, M., C. D. Gocke, C. B. Kobrin, F. A. Benko, L. A. Sternas, R. Pennington, T. M. Watson, C. W. Reynolds, B. L. Cause, P. L. Duffey, et al. 1999. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat. Med. 5: 1171-1177.
57. Baskar, S., C. B. Kobrin, and L. W. Kwak. 2004. Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes. J. Clin. Invest. 113: 1498-1510.